Herbert Tilg

Research interests

Publications

• Global burden of metabolic diseases, 1990–2021

  Metabolism · 2024 · https://doi.org/10.1016/j.metabol.2024.155999

• Gut microbiome and health: mechanistic insights

  Gut · 2022 · https://doi.org/10.1136/gutjnl-2021-326789

• Gut-liver axis: Pathophysiological concepts and clinical implications

  Cell Metabolism · 2022 · https://doi.org/10.1016/j.cmet.2022.09.017

• Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

  Gut · 2022 · https://doi.org/10.1136/gutjnl-2022-327745

• Dietary spermidine improves cognitive function

  Cell Reports · 2021 · https://doi.org/10.1016/j.celrep.2021.108985

• Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease

  Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-15646-6

• Gut microbiome, liver immunology, and liver diseases

  Cellular and Molecular Immunology · 2020 · https://doi.org/10.1038/s41423-020-00592-6

• The intestinal microbiota fuelling metabolic inflammation

  Nature reviews. Immunology · 2019 · https://doi.org/10.1038/s41577-019-0198-4

• Higher spermidine intake is linked to lower mortality: a prospective population-based study

  American Journal of Clinical Nutrition · 2018 · https://doi.org/10.1093/ajcn/nqy102

• A guiding map for inflammation

  Nature Immunology · 2017 · 10.1038/ni.3790

• European consensus conference on faecal microbiota transplantation in clinical practice

  Gut · 2017 · 10.1136/gutjnl-2016-313017

• Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.12.020

• Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes

  Diabetes · 2016 · https://doi.org/10.2337/db16-0731

• 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

  Journal of Crohn s and Colitis · 2016 · https://doi.org/10.1093/ecco-jcc/jjw168

• The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

  Journal of Crohn s and Colitis · 2015 · https://doi.org/10.1093/ecco-jcc/jjv213

• Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

  Gut · 2015 · 10.1136/gutjnl-2015-309800

• Intestinal permeability – a new target for disease prevention and therapy

  BMC Gastroenterology · 2014 · https://doi.org/10.1186/s12876-014-0189-7

• Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

  Journal of Crohn s and Colitis · 2014 · https://doi.org/10.1016/j.crohns.2013.12.013

• Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

  Nature Medicine · 2013 · https://doi.org/10.1038/nm.3084

• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

  Journal of Crohn s and Colitis · 2012 · https://doi.org/10.1016/j.crohns.2012.09.005

• Development of the Crohnʼs disease digestive damage score, the Lémann score

  Inflammatory Bowel Diseases · 2010 · https://doi.org/10.1002/ibd.21506

• Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis

  Hepatology · 2010 · https://doi.org/10.1002/hep.24001

• A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease

  Journal of Crohn s and Colitis · 2010 · https://doi.org/10.1016/j.crohns.2009.12.001

• The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

  Journal of Crohn s and Colitis · 2009 · 10.1016/j.crohns.2009.09.009

• Gut, inflammation and osteoporosis: basic and clinical concepts

  Gut · 2008 · https://doi.org/10.1136/gut.2006.117382

• Adipocytokines: mediators linking adipose tissue, inflammation and immunity

  Nature reviews. Immunology · 2006 · https://doi.org/10.1038/nri1937

• Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

  Gastroenterology · 2004 · https://doi.org/10.1053/j.gastro.2004.04.009

Current projects

No projects listed.